Suggested Searches
View All
View All
View All
General Results

News & Stories

M Health Fairview honored for leadership in the fight against cancer

The American Cancer Society of Minnesota recently recognized M Health Fairview for extraordinary contributions in cancer care, both within and outside of our walls.
M Health Fairview Hematologist/Oncologist Claudio G. Brunstein, MD, PhD, pictured at right, was a 2019 Spirit of Hope award honoree.

M Health Fairview has been recognized as the 2020 medical recipient of the American Cancer Society Minnesota Made Spirit of Hope Award. The Spirit of Hope Award is a prestigious local honor for an individual or organization with extraordinary contributions to the fight against cancer through humanitarian service and distinguished leadership.

“M Health Fairview and the American Cancer Society have a long history of partnership, and we are honored to be recognized as the 2020 Minnesota Made Spirit of Hope medical honoree,” said Marie Brown, MHA, FACHE, cancer care service line executive.

Our system helped bring the American Cancer Society’s Twin Cities Hope Lodge from concept to reality in 2007. Hope Lodge provides a place for cancer patients and families to stay during treatment, and our patients regularly use the facility today as they travel from long distances to receive our expert care. Fairview President and CEO James Hereford is also part of the cancer society’s CEOs Against Cancer chapter, a collective of business leaders joining the fight against cancer.

Our partnership has deep roots. Since 1946, the American Cancer Society has awarded our research partners — the Masonic Cancer Center at the University of Minnesota — several million dollars a year to support research projects to fight cancer. This funding supports bench and bedside research that benefits patients in our system and the cancer community as a whole.

“It is so incredibly important that we continue these discoveries, and we are grateful for the support the American Cancer Society has provided us over the years,” Brown said.

Learn how a ground-breaking clinical trial turned the tide after this patient’s rare cancer diagnosis.